BIOMAT Database Logo BIOMAT Database Logo

[Chemotheray of malignant tumors. VIII. Hormones]. 1980

M Beran, and M Semonský, and S Semonská

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011372 Progestins Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. Gestagenic Agent,Progestagen,Progestagenic Agent,Progestational Agent,Progestational Compound,Progestational Hormone,Progestogen,Progestogens,Gestagen,Gestagen Effect,Gestagen Effects,Gestagenic Agents,Gestagenic Effect,Gestagenic Effects,Gestagens,Progestagenic Agents,Progestagens,Progestational Agents,Progestational Compounds,Progestational Hormones,Progestin,Progestin Effect,Progestin Effects,Progestogen Effect,Progestogen Effects,Agent, Gestagenic,Agent, Progestagenic,Agent, Progestational,Compound, Progestational,Effect, Gestagen,Effect, Gestagenic,Effect, Progestin,Effect, Progestogen,Effects, Gestagen,Effects, Gestagenic,Effects, Progestin,Effects, Progestogen,Hormone, Progestational
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012739 Gonadal Steroid Hormones Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE. Gonadal Steroid Hormone,Sex Hormone,Sex Steroid Hormone,Sex Steroid Hormones,Sex Hormones,Hormone, Gonadal Steroid,Hormone, Sex,Hormone, Sex Steroid,Hormones, Gonadal Steroid,Hormones, Sex Steroid,Steroid Hormone, Gonadal,Steroid Hormone, Sex,Steroid Hormones, Gonadal,Steroid Hormones, Sex

Related Publications

M Beran, and M Semonský, and S Semonská
[Hormones and malignant tumors].
January 1966, La Rassegna di clinica, terapia e scienze affini,
M Beran, and M Semonský, and S Semonská
[Malignant tumors producing parathyroid hormones].
January 1970, L'Annee endocrinologique,
M Beran, and M Semonský, and S Semonská
[Secretion of hormones by malignant tumors].
January 1987, Eksperimental'naia onkologiia,
M Beran, and M Semonský, and S Semonská
[Vascular tumors VIII: Angiomatoid malignant fibrous histiocytoma].
January 1983, VASA. Zeitschrift fur Gefasskrankheiten,
M Beran, and M Semonský, and S Semonská
[The effect of hormones on malignant tumors].
January 1955, Wiener klinische Wochenschrift,
M Beran, and M Semonský, and S Semonská
[Modified chemotherapy of malignant tumors with glucocorticoids and sex hormones].
May 1961, Deutsches medizinisches Journal,
M Beran, and M Semonský, and S Semonská
[Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
January 1984, Voprosy onkologii,
M Beran, and M Semonský, and S Semonská
[Hormones in the pathogenesis and treatment of malignant ovarian tumors].
January 1977, Voprosy onkologii,
M Beran, and M Semonský, and S Semonská
[Therapy of malignant tumors with anterior pituitary-adrenal cortex hormones].
October 1954, Therapeutische Umschau. Revue therapeutique,
M Beran, and M Semonský, and S Semonská
[Letter: Responsibility of steroid hormones in the development of malignant tumors].
April 1976, La Nouvelle presse medicale,
Copied contents to your clipboard!